FDA Drug recall D-1426-2020
Minoxidil/Biotin/Spironolactone 1.25/5/25mg capsules, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (86…
- FDA Drug
- Class II
- terminated
- Published 2020-08-05
On 2020-08-05 the FDA classified a Class II recall of Minoxidil/Biotin/Spironolactone 1.25/5/25mg capsules, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (86… by Masterpharm, citing lack of Processing Controls (lack of assurance of conformity to specifications).
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1426-2020 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2020-07-02 |
| Published | 2020-08-05 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Masterpharm |
| Distribution | US |
Product
Minoxidil/Biotin/Spironolactone 1.25/5/25mg capsules, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600
Reason
Lack of Processing Controls (lack of assurance of conformity to specifications).
Identifiers
| code_info | 01-16-2020:70@11, BUD 7/14/2020 01-30-2020:87@9, BUD 7/28/2020 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1426-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.